Physician profile
Steven A Haley
NPI 1811913890
$8,417.49
in general payments reported to CMS, 2019-2025
47 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $564 · 2021: $852 · 2022: $1,167 · 2023: $1,734 · 2024: $1,586 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,057.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $886.79 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Linq II |
| Merck Sharp & Dohme LLC | $792.10 | 2021-2025 | Verquvo, Belsomra |
| Alnylam Pharmaceuticals INC. | $719.89 | 2021-2025 | Onpattro, Amvuttra |
| Pfizer INC. | $714.28 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $634.94 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $513.71 | 2020-2025 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $476.47 | 2019-2025 | |
| Amgen INC. | $379.02 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $350.35 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.11 | 2019-2025 | Lifevest |
| Aop Health US, LLC | $273.63 | 2025 | Rapiblyk |
| Abbott Laboratories | $265.53 | 2019-2024 | Jot Dx |
| Boston Scientific Corporation | $262.04 | 2019-2025 | Watchman Flx, Watchman Access System |
| Amarin Pharma, INC. | $183.73 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.32 | 2021-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $128.14 | 2020-2025 | Extended Holter, Event, (Ck4) Mcot |
| Chiesi USA, INC. | $125.02 | 2020-2024 | Kengreal, Cleviprex |
| Novo Nordisk INC | $117.02 | 2024-2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $115.34 | 2019-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $98.33 | 2021-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.41 | 2023-2025 | Jardiance |
| Nuwellis, INC. | $88.83 | 2025 | Aquadex Smartflow Console |
| Edwards Lifesciences Corporation | $83.09 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cvrx, INC. | $51.03 | 2024-2025 | Barostim Neo System |
| Abiomed | $43.43 | 2025 | |
| Baxter Healthcare | $40.20 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Bardy Diagnostics, INC. | $39.64 | 2019-2020 | |
| Inspire Medical Systems, INC. | $39.38 | 2025 | Inspire |
| Lexicon Pharmaceuticals, INC. | $38.85 | 2023 | Inpefa |
| Biosense Webster, INC. | $37.97 | 2024 | Carto 3 |
| Atricure, INC. | $37.43 | 2022 | |
| Silk Road Medical, INC. | $31.81 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Regeneron Healthcare Solutions, INC. | $31.59 | 2019 | |
| Impulse Dynamics (USA) INC. | $28.90 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $25.68 | 2024 | Arcalyst |
| Bracco Diagnostics INC. | $24.53 | 2020 | |
| Alexion Pharmaceuticals, INC. | $22.84 | 2024 | Ultomiris |
| La Jolla Pharmaceutical Company | $22.26 | 2024 | Giapreza |
| Vital Connect, INC | $20.79 | 2023 | Vitalpatch Rtm |
| Acarix USA INC. | $19.44 | 2022 | |
| Lundbeck LLC | $19.29 | 2019 | |
| Smith+Nephew, INC. | $18.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.15 | 2021 | |
| Lilly USA, LLC | $16.06 | 2020 | |
| Medtronic Vascular, INC. | $14.44 | 2020 | |
| G Medical Diagnostic Services, INC. | $13.11 | 2023 | Cardiac Monitoring Suite |
| Cmp Pharma, INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.